Articles by Jill Wechsler - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jill Wechsler

Jill Wechsler


Jill Wechsler is BioPharm International's Washington editor.

Articles
FDA and Manufacturers Seek a More Secure Drug Supply Chain
April 1, 2014

New identifiers and tracking requirements aim to block illegitimate products.

Manufacturers Struggle with Breakthrough Drug Development
March 1, 2014

Accelerated testing and production create challenges in documenting product quality.

FDA Outlines Agenda for New Guidances in 2014
February 5, 2014

FDA plans to issue a number of new guidances in 2014 that will address drug development and manufacturing practices.

Metrics Sought to Ensure Drug Quality
January 1, 2014

Regulators work with manufacturers to improve systems for measuring product performance and manufacturing reliability.

Super Oversight for Generics
December 12, 2013

OGD is under pressure to improve review operations.

Analyzing Nano Drugs
December 12, 2013

FDA details efforts to evaluate potential risks from use of nanomaterials in drug products and discuss analytical considerations, impact on stability, safety, and toxicology effects.

Opioid Regulation Challenges FDA and Manufacturers
December 1, 2013

New policies and products seek to maintain access to pain medicines while curbing rampant abuse.

Congress Revises Rules for Drug Compounding and Supply-Chain Security
November 1, 2013

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.

PhRMA Report Shows New Vaccine Development
October 4, 2013

PhRMA report reflects robust R&D in vaccine development.

ADVERTISEMENT

ADVERTISEMENT

Click here